Virax Biolabs Group
(NASDAQ) VRAX
Virax Biolabs Group Financials at a Glance
Market Cap
$1.29M
Revenue (TTM)
$87.86K
Net Income (TTM)
$12.22M
EPS (TTM)
$-1.25
P/E Ratio
-0.14
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.18
Volume
45,969
Open
$0.18
Price
$0.18
Volume
45,969
Open
$0.18
Previous Close
$0.17
Daily Range
$0.17 - $0.19
52-Week Range
$0.17 - $1.35
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.18
Volume
45,969
Open
$0.18
Previous Close
$0.17
Daily Range
$0.17 - $0.19
52-Week Range
$0.17 - $1.35
VRAX News
VRAX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Virax Biolabs Group
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
19
CEO
James Foster
Website
www.viraxbiolabs.comHeadquarters
London, W1F 8LX, GB
VRAX Financials
Key Financial Metrics (TTM)
Gross Margin
-88%
Operating Margin
-1966%
Net Income Margin
-1890%
Return on Equity
-81%
Return on Capital
-1%
Return on Assets
-99%
Earnings Yield
-7.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.29M
Shares Outstanding
7.42M
Volume
45.97K
Short Interest
0.00%
Avg. Volume
288.50K
Financials (TTM)
Gross Profit
$53.07K
Operating Income
$6.16M
EBITDA
$5.80M
Operating Cash Flow
$4.56M
Capital Expenditure
$603.89K
Free Cash Flow
$5.17M
Cash & ST Invst.
$4.23M
Total Debt
$377.00K
Virax Biolabs Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.61K
-97.9%
Gross Profit
$215.41K
-2148.1%
Gross Margin
-133.96%
N/A
Market Cap
$1.29M
N/A
Market Cap/Employee
$75.63K
N/A
Employees
17
N/A
Net Income
$2.34M
+19.6%
EBITDA
$2.37M
+11.9%
Quarterly Fundamentals
Net Cash
$2.81M
-43.0%
Accounts Receivable
$175.70K
-4.2%
Inventory
$54.19K
+121.1%
Long Term Debt
$276.04K
+109.1%
Short Term Debt
$261.95K
+427.3%
Return on Assets
-98.75%
N/A
Return on Invested Capital
-1.10%
N/A
Free Cash Flow
$3.06M
+26.4%
Operating Cash Flow
$2.92M
+15.5%